Scientists "Tinker" With HIV Drug Chemistry Hoping to Reduce Costs
May 13, 2011
The Clinton Health Access Initiative, founded by former President Bill Clinton, with funding from the Bill & Melinda Gates Foundation and the U.K. government, has hired former pharmaceutical company scientists "to tinker with the chemistry used to synthesize a key [HIV] drug, tenofovir" in an effort to reduce "the cost of manufacturing," the Wall Street Journal reports.
"The chemistry effort represents a new sophistication among AIDS advocates, who fear a wave of HIV deaths in developing countries due to flat funding for international treatment programs," the newspaper writes. The Clinton team is also looking at how to make antiretroviral drugs that are more easily absorbed by the body, which "would allow each pill to contain less antiretroviral medication while achieving the same effects," according to the Wall Street Journal (Schoofs, 5/13).
Expanded Indication for Viread, to Include the Treatment of Patients 12 to Less Than 18 Years of Age
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)